Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trialIf approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients ...
Villages along Haryana's Ghaggar river face a cancer crisis linked to polluted water, prompting urgent calls for government ...
Trastuzumab pamirtecan, a novel antibody-drug conjugate, showed initial efficacy signals in pretreated patients with ...
Cancer is often perceived as a disease that strikes without warning. However, growing evidence shows that many cancers are closely linked to everyday lifestyle choices. In ...
Advanced liver disease (ALD) occurs when significant scarring causes the liver to lose function. Patients with ALD often have ...
FDA has accepted and granted Priority Review to the biologics license application for ifinatamab deruxtecan in adults with ...
ETHealthworld.com brings latest molecular diagnostics news, views and updates from all top sources for the Indian Health industry.
Trial met all primary and key secondary endpoints, including progression-free survival and overall survival Company intends ...
Lung cancer is the deadliest cancer—but early screening can save lives. A survivor’s story and expert insight show why ...
Dick Vitale has melanoma in his lung and liver cavity and will be starting immunotherapy soon, the legendary college ...
University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...
Famed ESPN broadcaster Dick Vitale is facing another battle with cancer. Vitale said Monday that biopsy results had confirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results